Skip to main content
. 2021 Aug 4;2021:5527387. doi: 10.1155/2021/5527387

Figure 2.

Figure 2

Survival analysis of patients with gastric cancer according to the expression of PLEK2. (a) The effect of PLEK2 on overall survival using 574 cancer samples based on the Kaplan-Meier plotter. (b) Examples of gastric cancer tissues immunostained for PLEK2. Different PLEK2 staining intensities are exemplified. (c) Kaplan-Meier analysis of overall survival in patients with gastric cancer (n = 108, P = 0.0042). HR: hazard ratio.